GH – guardant health, inc. (US:NASDAQ)
Stock Stats
News
Guardant Health, Inc. (NASDAQ: GH) was upgraded by analysts at Mizuho to a "strong-buy" rating.
Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025
Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at Barclays PLC from $60.00 to $55.00. They now have an "overweight" rating on the stock.
Guardant Health, Inc. (NASDAQ: GH) is now covered by analysts at Mizuho. They set an "outperform" rating and a $55.00 price target on the stock.
Alpenglow Biosciences Expands Advisory Board with Two Esteemed Industry Leaders [Yahoo! Finance]
Form 144 Guardant Health, Inc. Filed by: Tariq Musa
Form SCHEDULE 13G/A Guardant Health, Inc. Filed by: BlackRock, Inc.
Form 4 Guardant Health, Inc. For: Apr 15 Filed by: Tariq Musa
Form 4 Guardant Health, Inc. For: Apr 15 Filed by: Saia John G.
Form 4 Guardant Health, Inc. For: Apr 15 Filed by: POTTER MYRTLE S
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.